Summary

The global Neurovascular Microcatheters market is projected to grow from US$ 704 million in 2025 to US$ 1147 million by 2032, at a CAGR of 7.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Neurovascular Microcatheters are small-diameter, flexible, single-use intravascular catheters engineered for selective and superselective navigation through the complex and tortuous cerebral vasculature during neuroendovascular procedures. They provide a controlled pathway for delivering contrast media, embolic agents, detachable coils, intracranial stents, flow diverters, thrombectomy-related devices, and other compatible therapeutic systems to target lesions. Typical products integrate low-friction inner liners, variable-stiffness shafts, braided or coil reinforcement, hydrophilic surface technologies, atraumatic distal segments, radiopaque markers, and optimized lumen dimensions to balance trackability, pushability, torque response, kink resistance, and distal flexibility. The market primarily covers Single-Lumen Microcatheters and Dual-Lumen Balloon Microcatheters, with key clinical applications in intracranial aneurysm treatment, arteriovenous malformation and fistula embolization, acute ischemic stroke intervention, and other neuroendovascular therapies. Product differentiation is increasingly determined by inner diameter, distal profile, device compatibility, embolic-agent compatibility, working length, tip configuration, and the ability to maintain stable access in highly tortuous anatomy.
Key Findings
Single-Lumen Microcatheters remain the mainstream product architecture, while Dual-Lumen Balloon Microcatheters address more specialized embolization procedures
Intracranial aneurysm treatment, vascular malformation embolization, and acute ischemic stroke intervention constitute the principal clinical demand base
Hospitals remain the dominant end-use setting because neurointerventional procedures require specialized imaging, physician expertise, anesthesia, and perioperative support
North America represents the leading high-value regional market, while Asia Pacific is becoming an increasingly important source of incremental demand
Market Trends
The Neurovascular Microcatheters market is shifting from basic catheter access toward increasingly procedure-specific delivery platforms. Product development is focused on lower distal profiles, improved trackability through tortuous cerebral anatomy, greater resistance to kinking and ovalization, enhanced radiopacity, and more consistent transmission of push and torque from the proximal shaft to the distal tip. Compatibility with detachable coils, liquid embolic agents, low-profile intracranial stents, flow-diversion systems, and thrombectomy devices is becoming a more important competitive parameter as neurointerventional procedures increasingly rely on integrated device systems rather than isolated components. Manufacturers are also refining catheter architecture through multi-zone stiffness transitions, advanced polymer combinations, optimized braid or coil reinforcement, hydrophilic coatings, and more precisely engineered inner lumens. At the clinical level, demand is moving toward platforms capable of reaching more distal and anatomically challenging targets while minimizing vessel trauma and facilitating predictable device deployment. This trend favors suppliers that can combine microcatheter design with a broader neurovascular portfolio and demonstrate compatibility across access, embolization, aneurysm treatment, and stroke intervention workflows.
Market Dynamics
Drivers
Growth in Neurovascular Microcatheters is supported by the expanding use of minimally invasive endovascular treatment for intracranial aneurysms, ischemic stroke, cerebral arteriovenous malformations, and other cerebrovascular disorders. Increasing availability of comprehensive stroke centers and neurointerventional specialists is expanding the addressable procedural base, while advances in coils, flow diverters, liquid embolics, intracranial stents, and thrombectomy systems create additional demand for compatible microcatheter platforms. Continuous improvements in distal access, catheter flexibility, and device deliverability are also enabling physicians to treat lesions that were previously difficult to reach through endovascular approaches.
Restraints
The market remains constrained by demanding product development and regulatory requirements, as performance failures in small and tortuous cerebral vessels can have significant clinical consequences. Precision extrusion, reinforcement, coating, bonding, marker placement, and sterilization require tightly controlled manufacturing processes, while product qualification and clinical validation increase development costs and extend commercialization cycles. Hospital procurement pressure and increasing price competition, particularly where multiple technically comparable products are available, can limit pricing flexibility. Adoption of new products can also be gradual because neurointerventional physicians typically require substantial procedural experience before changing established access and delivery platforms.
Opportunities
Future opportunities are concentrated in lower-profile delivery systems, advanced balloon microcatheters, embolic-compatible platforms, and microcatheters optimized for next-generation aneurysm and stroke devices. Expansion of neurointerventional capacity across China and other emerging healthcare markets creates additional opportunities as the number of specialized treatment centers and trained physicians increases. Local manufacturers with competitive manufacturing economics and improving clinical evidence can capture a larger share of price-sensitive markets, while multinational suppliers can benefit from broader device-system integration and premium product positioning. Additional opportunity exists in designing microcatheters around specific therapeutic platforms, enabling manufacturers to capture value across a complete procedural workflow rather than competing solely on catheter specifications.
Challenges
Long-term competition increasingly depends on achieving simultaneous improvements in flexibility, support, trackability, lumen size, and structural integrity, characteristics that often involve engineering trade-offs. Compatibility requirements are also becoming more complex as the number of coils, embolic materials, stents, flow diverters, and thrombectomy devices expands. Clinical performance remains highly operator-dependent, making physician training and technical support important elements of commercialization. Product quality events, vessel injury risks, and regulatory scrutiny can materially affect brand adoption, while rapid product iteration requires manufacturers to sustain investment in research, tooling, validation, and international registrations. Regional differences in reimbursement, procurement practices, physician preferences, and regulatory pathways further complicate global commercialization.
Industry Chain Analysis
The upstream industry chain for Neurovascular Microcatheters includes medical-grade thermoplastic polymers, low-friction liner materials, stainless-steel or nickel-titanium reinforcement wires, radiopaque marker materials, hydrophilic coating systems, adhesives, connectors, and other precision catheter components. Manufacturing requires a combination of micro-extrusion, multilayer tubing, braid or coil reinforcement, thermal bonding, distal-tip forming, marker assembly, coating, dimensional inspection, packaging, and sterilization. Material selection and process control directly influence catheter profile, lumen stability, flexibility, torque transmission, surface friction, radiopacity, and biocompatibility, creating meaningful technical barriers even when the external product form appears relatively standardized.
At the midstream level, value creation is concentrated in catheter architecture, precision manufacturing, proprietary process know-how, device compatibility, quality systems, regulatory registrations, and clinical validation. Downstream demand is dominated by hospitals and specialist neurointerventional centers, with purchasing decisions influenced by physician experience, procedural compatibility, clinical evidence, hospital procurement systems, and distributor coverage. The category generally supports relatively strong gross margins compared with conventional commodity catheters, although these margins are offset by substantial expenditure on research and development, regulatory compliance, quality assurance, physician education, inventory management, and specialized commercial support. Suppliers with integrated neurovascular portfolios can also generate additional value through procedural bundling and compatibility across multiple devices.
Segment Insights
By Product Type, Single-Lumen Microcatheters account for the mainstream market because they support a broad range of neurointerventional procedures and can be configured for coil delivery, embolic-agent infusion, intracranial device delivery, and thrombectomy-related access. Dual-Lumen Balloon Microcatheters represent a more specialized segment, with their value concentrated in procedures requiring temporary flow control, balloon-assisted embolization, or enhanced control of liquid embolic delivery. Although their unit penetration is lower, technically differentiated balloon designs can support higher-value applications where procedural control is critical.
Product segmentation by Inner Diameter provides an additional view of competitive positioning. Platforms around the smaller lumen range are widely used for coil embolization, selective catheterization, and distal embolic delivery because of their favorable low-profile characteristics, while larger lumen configurations increasingly support intracranial stents, flow diverters, and other devices requiring greater delivery clearance. By Clinical Application, intracranial aneurysm treatment remains a major demand pool, complemented by arteriovenous malformation and fistula embolization and acute ischemic stroke procedures. The market therefore rewards manufacturers capable of maintaining a broad specification portfolio rather than relying on a single universal microcatheter platform.
Downstream Market Opportunities
Hospitals with established neurointerventional, neurosurgical, stroke, and interventional radiology capabilities form the core downstream market for Neurovascular Microcatheters. Expansion opportunities are closely linked to the development of comprehensive stroke networks, broader availability of mechanical thrombectomy and aneurysm treatment, and increasing treatment of complex vascular malformations through endovascular approaches. Demand is also becoming more specification-driven as physicians require different lumen sizes, distal profiles, working lengths, and tip configurations for specific anatomies and therapeutic devices. This creates opportunities for suppliers that can offer coherent product families covering multiple procedural requirements, particularly in emerging neurointerventional centers that are expanding from basic stroke treatment toward comprehensive aneurysm and embolization capabilities.
Regional Insights
North America remains the leading high-value market for Neurovascular Microcatheters, supported by an established neurointerventional infrastructure, high adoption of advanced aneurysm and stroke procedures, broad access to premium devices, and strong participation from major global neurovascular manufacturers. Europe also represents a mature market with established clinical expertise and a significant base of specialized neurovascular device companies. In these developed markets, competition increasingly emphasizes clinical evidence, procedural efficiency, device compatibility, and incremental improvements in deliverability rather than basic catheter availability.
Asia Pacific represents an increasingly important incremental growth market. China combines expanding neurointerventional capacity with a rapidly developing domestic medical-device manufacturing base, creating simultaneous opportunities for procedural volume growth and local substitution. Japan remains an established market for highly engineered catheter technologies, while other Asian markets are expanding as specialist treatment infrastructure improves. Regional price differences remain material, and manufacturers therefore require differentiated commercialization strategies: premium technology and integrated procedural portfolios are particularly important in mature markets, whereas product accessibility, registration coverage, local clinical evidence, and cost-performance balance play a larger role in many emerging markets.
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Neurovascular Microcatheters market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Stryker Corporation
Medtronic plc
Johnson & Johnson
Penumbra, Inc.
MicroVention, Inc. (d/b/a Terumo Neuro)
Balt Group
Acandis GmbH
Bendit Technologies Ltd.
Kaneka Corporation
Fuji Systems Corporation
Genesis MedTech Group
HeMo Bioengineering Limited
GRK Medical Devices Pvt. Ltd.
Wallaby Medical Holding, Inc.
MicroPort NeuroTech (Shanghai) Co., Ltd.
Zylox-Tonbridge Medical Technology Co., Ltd.
Shanghai HeartCare Medical Technology Corporation Limited
AccuMedical Beijing Inc.
Shanghai Achieva Medical Suzhou Co., Ltd.
Segment by Type
Single-Lumen Microcatheters
Dual-Lumen Balloon Microcatheters
Segment by Tip Shapeability
Steam-Shapeable Tip
Fixed-Shape Tip
Others
Segment by Radiopaque Marker Configuration
Single Distal Marker
Dual Distal Markers
Segment by Application
Intracranial Aneurysm
Arteriovenous Malformation and Fistula
Acute Ischemic Stroke
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
Europe
Germany
France
U.K.
Italy
Russia
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Neurovascular Microcatheters study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Neurovascular Microcatheters: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Neurovascular Microcatheters Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Single-Lumen Microcatheters
1.2.3 Dual-Lumen Balloon Microcatheters
1.3 Market Segmentation by Tip Shapeability
1.3.1 Global Neurovascular Microcatheters Market Size by Tip Shapeability, 2021 vs 2025 vs 2032
1.3.2 Steam-Shapeable Tip
1.3.3 Fixed-Shape Tip
1.3.4 Others
1.4 Market Segmentation by Radiopaque Marker Configuration
1.4.1 Global Neurovascular Microcatheters Market Size by Radiopaque Marker Configuration, 2021 vs 2025 vs 2032
1.4.2 Single Distal Marker
1.4.3 Dual Distal Markers
1.5 Market Segmentation by Application
1.5.1 Global Neurovascular Microcatheters Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Intracranial Aneurysm
1.5.3 Arteriovenous Malformation and Fistula
1.5.4 Acute Ischemic Stroke
1.5.5 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Global Neurovascular Microcatheters Revenue Estimates and Forecasts (2021-2032)
2.2 Global Neurovascular Microcatheters Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Neurovascular Microcatheters Sales Estimates and Forecasts (2021-2032)
2.4 Global Neurovascular Microcatheters Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)

3 Competitive Landscape
3.1 Global Neurovascular Microcatheters Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Neurovascular Microcatheters Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Single-Lumen Microcatheters: Market Share by Key Manufacturers
3.5.2 Dual-Lumen Balloon Microcatheters: Market Share by Key Manufacturers
3.6 Global Neurovascular Microcatheters Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation
4.1 Global Neurovascular Microcatheters Sales Performance by Type
4.1.1 Global Neurovascular Microcatheters Sales Volume by Type (2021-2032)
4.1.2 Global Neurovascular Microcatheters Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Neurovascular Microcatheters Sales Performance by Tip Shapeability
4.2.1 Global Neurovascular Microcatheters Sales Volume by Tip Shapeability (2021-2032)
4.2.2 Global Neurovascular Microcatheters Revenue by Tip Shapeability (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Tip Shapeability (2021-2032)
4.3 Global Neurovascular Microcatheters Sales Performance by Radiopaque Marker Configuration
4.3.1 Global Neurovascular Microcatheters Sales Volume by Radiopaque Marker Configuration (2021-2032)
4.3.2 Global Neurovascular Microcatheters Revenue by Radiopaque Marker Configuration (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Radiopaque Marker Configuration (2021-2032)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global Neurovascular Microcatheters Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Neurovascular Microcatheters Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application

6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Neurovascular Microcatheters Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Neurovascular Microcatheters Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico

7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Neurovascular Microcatheters Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Neurovascular Microcatheters Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia

8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Neurovascular Microcatheters Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Neurovascular Microcatheters Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India

9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Neurovascular Microcatheters Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Neurovascular Microcatheters Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Neurovascular Microcatheters Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Neurovascular Microcatheters Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 Stryker Corporation
11.1.1 Stryker Corporation Corporation Information
11.1.2 Stryker Corporation Business Overview
11.1.3 Stryker Corporation Neurovascular Microcatheters Product Models, Descriptions and Specifications
11.1.4 Stryker Corporation Neurovascular Microcatheters Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Stryker Corporation Neurovascular Microcatheters Sales by Product in 2025
11.1.6 Stryker Corporation Neurovascular Microcatheters Sales by Application in 2025
11.1.7 Stryker Corporation Neurovascular Microcatheters Sales by Geographic Area in 2025
11.1.8 Stryker Corporation Neurovascular Microcatheters SWOT Analysis
11.1.9 Stryker Corporation Recent Developments
11.2 Medtronic plc
11.2.1 Medtronic plc Corporation Information
11.2.2 Medtronic plc Business Overview
11.2.3 Medtronic plc Neurovascular Microcatheters Product Models, Descriptions and Specifications
11.2.4 Medtronic plc Neurovascular Microcatheters Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Medtronic plc Neurovascular Microcatheters Sales by Product in 2025
11.2.6 Medtronic plc Neurovascular Microcatheters Sales by Application in 2025
11.2.7 Medtronic plc Neurovascular Microcatheters Sales by Geographic Area in 2025
11.2.8 Medtronic plc Neurovascular Microcatheters SWOT Analysis
11.2.9 Medtronic plc Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Neurovascular Microcatheters Product Models, Descriptions and Specifications
11.3.4 Johnson & Johnson Neurovascular Microcatheters Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Johnson & Johnson Neurovascular Microcatheters Sales by Product in 2025
11.3.6 Johnson & Johnson Neurovascular Microcatheters Sales by Application in 2025
11.3.7 Johnson & Johnson Neurovascular Microcatheters Sales by Geographic Area in 2025
11.3.8 Johnson & Johnson Neurovascular Microcatheters SWOT Analysis
11.3.9 Johnson & Johnson Recent Developments
11.4 Penumbra, Inc.
11.4.1 Penumbra, Inc. Corporation Information
11.4.2 Penumbra, Inc. Business Overview
11.4.3 Penumbra, Inc. Neurovascular Microcatheters Product Models, Descriptions and Specifications
11.4.4 Penumbra, Inc. Neurovascular Microcatheters Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Penumbra, Inc. Neurovascular Microcatheters Sales by Product in 2025
11.4.6 Penumbra, Inc. Neurovascular Microcatheters Sales by Application in 2025
11.4.7 Penumbra, Inc. Neurovascular Microcatheters Sales by Geographic Area in 2025
11.4.8 Penumbra, Inc. Neurovascular Microcatheters SWOT Analysis
11.4.9 Penumbra, Inc. Recent Developments
11.5 MicroVention, Inc. (d/b/a Terumo Neuro)
11.5.1 MicroVention, Inc. (d/b/a Terumo Neuro) Corporation Information
11.5.2 MicroVention, Inc. (d/b/a Terumo Neuro) Business Overview
11.5.3 MicroVention, Inc. (d/b/a Terumo Neuro) Neurovascular Microcatheters Product Models, Descriptions and Specifications
11.5.4 MicroVention, Inc. (d/b/a Terumo Neuro) Neurovascular Microcatheters Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 MicroVention, Inc. (d/b/a Terumo Neuro) Neurovascular Microcatheters Sales by Product in 2025
11.5.6 MicroVention, Inc. (d/b/a Terumo Neuro) Neurovascular Microcatheters Sales by Application in 2025
11.5.7 MicroVention, Inc. (d/b/a Terumo Neuro) Neurovascular Microcatheters Sales by Geographic Area in 2025
11.5.8 MicroVention, Inc. (d/b/a Terumo Neuro) Neurovascular Microcatheters SWOT Analysis
11.5.9 MicroVention, Inc. (d/b/a Terumo Neuro) Recent Developments
11.6 Balt Group
11.6.1 Balt Group Corporation Information
11.6.2 Balt Group Business Overview
11.6.3 Balt Group Neurovascular Microcatheters Product Models, Descriptions and Specifications
11.6.4 Balt Group Neurovascular Microcatheters Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 Balt Group Recent Developments
11.7 Acandis GmbH
11.7.1 Acandis GmbH Corporation Information
11.7.2 Acandis GmbH Business Overview
11.7.3 Acandis GmbH Neurovascular Microcatheters Product Models, Descriptions and Specifications
11.7.4 Acandis GmbH Neurovascular Microcatheters Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Acandis GmbH Recent Developments
11.8 Bendit Technologies Ltd.
11.8.1 Bendit Technologies Ltd. Corporation Information
11.8.2 Bendit Technologies Ltd. Business Overview
11.8.3 Bendit Technologies Ltd. Neurovascular Microcatheters Product Models, Descriptions and Specifications
11.8.4 Bendit Technologies Ltd. Neurovascular Microcatheters Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Bendit Technologies Ltd. Recent Developments
11.9 Kaneka Corporation
11.9.1 Kaneka Corporation Corporation Information
11.9.2 Kaneka Corporation Business Overview
11.9.3 Kaneka Corporation Neurovascular Microcatheters Product Models, Descriptions and Specifications
11.9.4 Kaneka Corporation Neurovascular Microcatheters Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 Kaneka Corporation Recent Developments
11.10 Fuji Systems Corporation
11.10.1 Fuji Systems Corporation Corporation Information
11.10.2 Fuji Systems Corporation Business Overview
11.10.3 Fuji Systems Corporation Neurovascular Microcatheters Product Models, Descriptions and Specifications
11.10.4 Fuji Systems Corporation Neurovascular Microcatheters Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Fuji Systems Corporation Recent Developments
11.11 Genesis MedTech Group
11.11.1 Genesis MedTech Group Corporation Information
11.11.2 Genesis MedTech Group Business Overview
11.11.3 Genesis MedTech Group Neurovascular Microcatheters Product Models, Descriptions and Specifications
11.11.4 Genesis MedTech Group Neurovascular Microcatheters Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 Genesis MedTech Group Recent Developments
11.12 HeMo Bioengineering Limited
11.12.1 HeMo Bioengineering Limited Corporation Information
11.12.2 HeMo Bioengineering Limited Business Overview
11.12.3 HeMo Bioengineering Limited Neurovascular Microcatheters Product Models, Descriptions and Specifications
11.12.4 HeMo Bioengineering Limited Neurovascular Microcatheters Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 HeMo Bioengineering Limited Recent Developments
11.13 GRK Medical Devices Pvt. Ltd.
11.13.1 GRK Medical Devices Pvt. Ltd. Corporation Information
11.13.2 GRK Medical Devices Pvt. Ltd. Business Overview
11.13.3 GRK Medical Devices Pvt. Ltd. Neurovascular Microcatheters Product Models, Descriptions and Specifications
11.13.4 GRK Medical Devices Pvt. Ltd. Neurovascular Microcatheters Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 GRK Medical Devices Pvt. Ltd. Recent Developments
11.14 Wallaby Medical Holding, Inc.
11.14.1 Wallaby Medical Holding, Inc. Corporation Information
11.14.2 Wallaby Medical Holding, Inc. Business Overview
11.14.3 Wallaby Medical Holding, Inc. Neurovascular Microcatheters Product Models, Descriptions and Specifications
11.14.4 Wallaby Medical Holding, Inc. Neurovascular Microcatheters Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 Wallaby Medical Holding, Inc. Recent Developments
11.15 MicroPort NeuroTech (Shanghai) Co., Ltd.
11.15.1 MicroPort NeuroTech (Shanghai) Co., Ltd. Corporation Information
11.15.2 MicroPort NeuroTech (Shanghai) Co., Ltd. Business Overview
11.15.3 MicroPort NeuroTech (Shanghai) Co., Ltd. Neurovascular Microcatheters Product Models, Descriptions and Specifications
11.15.4 MicroPort NeuroTech (Shanghai) Co., Ltd. Neurovascular Microcatheters Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 MicroPort NeuroTech (Shanghai) Co., Ltd. Recent Developments
11.16 Zylox-Tonbridge Medical Technology Co., Ltd.
11.16.1 Zylox-Tonbridge Medical Technology Co., Ltd. Corporation Information
11.16.2 Zylox-Tonbridge Medical Technology Co., Ltd. Business Overview
11.16.3 Zylox-Tonbridge Medical Technology Co., Ltd. Neurovascular Microcatheters Product Models, Descriptions and Specifications
11.16.4 Zylox-Tonbridge Medical Technology Co., Ltd. Neurovascular Microcatheters Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 Zylox-Tonbridge Medical Technology Co., Ltd. Recent Developments
11.17 Shanghai HeartCare Medical Technology Corporation Limited
11.17.1 Shanghai HeartCare Medical Technology Corporation Limited Corporation Information
11.17.2 Shanghai HeartCare Medical Technology Corporation Limited Business Overview
11.17.3 Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Microcatheters Product Models, Descriptions and Specifications
11.17.4 Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Microcatheters Sales, Price, Revenue and Gross Margin (2021-2026)
11.17.5 Shanghai HeartCare Medical Technology Corporation Limited Recent Developments
11.18 AccuMedical Beijing Inc.
11.18.1 AccuMedical Beijing Inc. Corporation Information
11.18.2 AccuMedical Beijing Inc. Business Overview
11.18.3 AccuMedical Beijing Inc. Neurovascular Microcatheters Product Models, Descriptions and Specifications
11.18.4 AccuMedical Beijing Inc. Neurovascular Microcatheters Sales, Price, Revenue and Gross Margin (2021-2026)
11.18.5 AccuMedical Beijing Inc. Recent Developments
11.19 Shanghai Achieva Medical Suzhou Co., Ltd.
11.19.1 Shanghai Achieva Medical Suzhou Co., Ltd. Corporation Information
11.19.2 Shanghai Achieva Medical Suzhou Co., Ltd. Business Overview
11.19.3 Shanghai Achieva Medical Suzhou Co., Ltd. Neurovascular Microcatheters Product Models, Descriptions and Specifications
11.19.4 Shanghai Achieva Medical Suzhou Co., Ltd. Neurovascular Microcatheters Sales, Price, Revenue and Gross Margin (2021-2026)
11.19.5 Shanghai Achieva Medical Suzhou Co., Ltd. Recent Developments

12 Value Chain and Supply-Chain Analysis
12.1 Neurovascular Microcatheters Industry Chain
12.2 Neurovascular Microcatheters Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Neurovascular Microcatheters Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Neurovascular Microcatheters Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Neurovascular Microcatheters Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs

14 Key Findings in the Global Neurovascular Microcatheters Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Neurovascular Microcatheters Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Neurovascular Microcatheters Market Size Growth Rate by Tip Shapeability, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Neurovascular Microcatheters Market Size Growth Rate by Radiopaque Marker Configuration, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Neurovascular Microcatheters Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Neurovascular Microcatheters Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Neurovascular Microcatheters Revenue by Region (US$ Million), 2021-2026
Table 7. Global Neurovascular Microcatheters Revenue by Region (US$ Million), 2027-2032
Table 8. Global Neurovascular Microcatheters Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 9. Global Neurovascular Microcatheters Sales by Region (K Units), 2021-2026
Table 10. Global Neurovascular Microcatheters Sales by Region (K Units), 2027-2032
Table 11. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 12. Global Neurovascular Microcatheters Sales by Manufacturers (K Units), 2021-2026
Table 13. Global Neurovascular Microcatheters Sales Share by Manufacturers (2021-2026)
Table 14. Global Neurovascular Microcatheters Revenue by Manufacturers (US$ Million), 2021-2026
Table 15. Global Neurovascular Microcatheters Revenue-Based Market Share by Manufacturers (2021-2026)
Table 16. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 17. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Neurovascular Microcatheters Revenue, 2025
Table 18. Global Neurovascular Microcatheters Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 19. Global Neurovascular Microcatheters Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
Table 20. Key Manufacturers Neurovascular Microcatheters Manufacturing Base and Headquarters
Table 21. Global Neurovascular Microcatheters Market Concentration Ratio (CR5)
Table 22. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 23. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 24. Global Neurovascular Microcatheters Sales Volume by Type (K Units), 2021-2026
Table 25. Global Neurovascular Microcatheters Sales Volume by Type (K Units), 2027-2032
Table 26. Global Neurovascular Microcatheters Revenue by Type (US$ Million), 2021-2026
Table 27. Global Neurovascular Microcatheters Revenue by Type (US$ Million), 2027-2032
Table 28. Global Neurovascular Microcatheters Sales Volume by Tip Shapeability (K Units), 2021-2026
Table 29. Global Neurovascular Microcatheters Sales Volume by Tip Shapeability (K Units), 2027-2032
Table 30. Global Neurovascular Microcatheters Revenue by Tip Shapeability (US$ Million), 2021-2026
Table 31. Global Neurovascular Microcatheters Revenue by Tip Shapeability (US$ Million), 2027-2032
Table 32. Global Neurovascular Microcatheters Sales Volume by Radiopaque Marker Configuration (K Units), 2021-2026
Table 33. Global Neurovascular Microcatheters Sales Volume by Radiopaque Marker Configuration (K Units), 2027-2032
Table 34. Global Neurovascular Microcatheters Revenue by Radiopaque Marker Configuration (US$ Million), 2021-2026
Table 35. Global Neurovascular Microcatheters Revenue by Radiopaque Marker Configuration (US$ Million), 2027-2032
Table 36. Technical Specifications by Key Product Type
Table 37. Global Neurovascular Microcatheters Sales by Application (K Units), 2021-2026
Table 38. Global Neurovascular Microcatheters Sales by Application (K Units), 2027-2032
Table 39. Neurovascular Microcatheters High-Growth Sectors Demand CAGR (2026-2032)
Table 40. Global Neurovascular Microcatheters Revenue by Application (US$ Million), 2021-2026
Table 41. Global Neurovascular Microcatheters Revenue by Application (US$ Million), 2027-2032
Table 42. Top Customers by Region
Table 43. Top Customers by Application
Table 44. North America Neurovascular Microcatheters Growth Accelerators and Market Barriers
Table 45. North America Neurovascular Microcatheters Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. North America Neurovascular Microcatheters Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 47. Europe Neurovascular Microcatheters Growth Accelerators and Market Barriers
Table 48. Europe Neurovascular Microcatheters Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 49. Europe Neurovascular Microcatheters Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 50. Asia-Pacific Neurovascular Microcatheters Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 51. Asia-Pacific Neurovascular Microcatheters Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 52. Asia-Pacific Neurovascular Microcatheters Growth Accelerators and Market Barriers
Table 53. Southeast Asia Neurovascular Microcatheters Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 54. Central and South America Neurovascular Microcatheters Investment Opportunities and Key Challenges
Table 55. Central and South America Neurovascular Microcatheters Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 56. Middle East and Africa Neurovascular Microcatheters Investment Opportunities and Key Challenges
Table 57. Middle East and Africa Neurovascular Microcatheters Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 58. Stryker Corporation Corporation Information
Table 59. Stryker Corporation Description and Major Businesses
Table 60. Stryker Corporation Product Models, Descriptions and Specifications
Table 61. Stryker Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 62. Stryker Corporation Sales Value Proportion by Product in 2025
Table 63. Stryker Corporation Sales Value Proportion by Application in 2025
Table 64. Stryker Corporation Sales Value Proportion by Geographic Area in 2025
Table 65. Stryker Corporation Neurovascular Microcatheters SWOT Analysis
Table 66. Stryker Corporation Recent Developments
Table 67. Medtronic plc Corporation Information
Table 68. Medtronic plc Description and Major Businesses
Table 69. Medtronic plc Product Models, Descriptions and Specifications
Table 70. Medtronic plc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. Medtronic plc Sales Value Proportion by Product in 2025
Table 72. Medtronic plc Sales Value Proportion by Application in 2025
Table 73. Medtronic plc Sales Value Proportion by Geographic Area in 2025
Table 74. Medtronic plc Neurovascular Microcatheters SWOT Analysis
Table 75. Medtronic plc Recent Developments
Table 76. Johnson & Johnson Corporation Information
Table 77. Johnson & Johnson Description and Major Businesses
Table 78. Johnson & Johnson Product Models, Descriptions and Specifications
Table 79. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Johnson & Johnson Sales Value Proportion by Product in 2025
Table 81. Johnson & Johnson Sales Value Proportion by Application in 2025
Table 82. Johnson & Johnson Sales Value Proportion by Geographic Area in 2025
Table 83. Johnson & Johnson Neurovascular Microcatheters SWOT Analysis
Table 84. Johnson & Johnson Recent Developments
Table 85. Penumbra, Inc. Corporation Information
Table 86. Penumbra, Inc. Description and Major Businesses
Table 87. Penumbra, Inc. Product Models, Descriptions and Specifications
Table 88. Penumbra, Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Penumbra, Inc. Sales Value Proportion by Product in 2025
Table 90. Penumbra, Inc. Sales Value Proportion by Application in 2025
Table 91. Penumbra, Inc. Sales Value Proportion by Geographic Area in 2025
Table 92. Penumbra, Inc. Neurovascular Microcatheters SWOT Analysis
Table 93. Penumbra, Inc. Recent Developments
Table 94. MicroVention, Inc. (d/b/a Terumo Neuro) Corporation Information
Table 95. MicroVention, Inc. (d/b/a Terumo Neuro) Description and Major Businesses
Table 96. MicroVention, Inc. (d/b/a Terumo Neuro) Product Models, Descriptions and Specifications
Table 97. MicroVention, Inc. (d/b/a Terumo Neuro) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. MicroVention, Inc. (d/b/a Terumo Neuro) Sales Value Proportion by Product in 2025
Table 99. MicroVention, Inc. (d/b/a Terumo Neuro) Sales Value Proportion by Application in 2025
Table 100. MicroVention, Inc. (d/b/a Terumo Neuro) Sales Value Proportion by Geographic Area in 2025
Table 101. MicroVention, Inc. (d/b/a Terumo Neuro) Neurovascular Microcatheters SWOT Analysis
Table 102. MicroVention, Inc. (d/b/a Terumo Neuro) Recent Developments
Table 103. Balt Group Corporation Information
Table 104. Balt Group Description and Major Businesses
Table 105. Balt Group Product Models, Descriptions and Specifications
Table 106. Balt Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Balt Group Recent Developments
Table 108. Acandis GmbH Corporation Information
Table 109. Acandis GmbH Description and Major Businesses
Table 110. Acandis GmbH Product Models, Descriptions and Specifications
Table 111. Acandis GmbH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Acandis GmbH Recent Developments
Table 113. Bendit Technologies Ltd. Corporation Information
Table 114. Bendit Technologies Ltd. Description and Major Businesses
Table 115. Bendit Technologies Ltd. Product Models, Descriptions and Specifications
Table 116. Bendit Technologies Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Bendit Technologies Ltd. Recent Developments
Table 118. Kaneka Corporation Corporation Information
Table 119. Kaneka Corporation Description and Major Businesses
Table 120. Kaneka Corporation Product Models, Descriptions and Specifications
Table 121. Kaneka Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Kaneka Corporation Recent Developments
Table 123. Fuji Systems Corporation Corporation Information
Table 124. Fuji Systems Corporation Description and Major Businesses
Table 125. Fuji Systems Corporation Product Models, Descriptions and Specifications
Table 126. Fuji Systems Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Fuji Systems Corporation Recent Developments
Table 128. Genesis MedTech Group Corporation Information
Table 129. Genesis MedTech Group Description and Major Businesses
Table 130. Genesis MedTech Group Product Models, Descriptions and Specifications
Table 131. Genesis MedTech Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Genesis MedTech Group Recent Developments
Table 133. HeMo Bioengineering Limited Corporation Information
Table 134. HeMo Bioengineering Limited Description and Major Businesses
Table 135. HeMo Bioengineering Limited Product Models, Descriptions and Specifications
Table 136. HeMo Bioengineering Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. HeMo Bioengineering Limited Recent Developments
Table 138. GRK Medical Devices Pvt. Ltd. Corporation Information
Table 139. GRK Medical Devices Pvt. Ltd. Description and Major Businesses
Table 140. GRK Medical Devices Pvt. Ltd. Product Models, Descriptions and Specifications
Table 141. GRK Medical Devices Pvt. Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. GRK Medical Devices Pvt. Ltd. Recent Developments
Table 143. Wallaby Medical Holding, Inc. Corporation Information
Table 144. Wallaby Medical Holding, Inc. Description and Major Businesses
Table 145. Wallaby Medical Holding, Inc. Product Models, Descriptions and Specifications
Table 146. Wallaby Medical Holding, Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Wallaby Medical Holding, Inc. Recent Developments
Table 148. MicroPort NeuroTech (Shanghai) Co., Ltd. Corporation Information
Table 149. MicroPort NeuroTech (Shanghai) Co., Ltd. Description and Major Businesses
Table 150. MicroPort NeuroTech (Shanghai) Co., Ltd. Product Models, Descriptions and Specifications
Table 151. MicroPort NeuroTech (Shanghai) Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. MicroPort NeuroTech (Shanghai) Co., Ltd. Recent Developments
Table 153. Zylox-Tonbridge Medical Technology Co., Ltd. Corporation Information
Table 154. Zylox-Tonbridge Medical Technology Co., Ltd. Description and Major Businesses
Table 155. Zylox-Tonbridge Medical Technology Co., Ltd. Product Models, Descriptions and Specifications
Table 156. Zylox-Tonbridge Medical Technology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Zylox-Tonbridge Medical Technology Co., Ltd. Recent Developments
Table 158. Shanghai HeartCare Medical Technology Corporation Limited Corporation Information
Table 159. Shanghai HeartCare Medical Technology Corporation Limited Description and Major Businesses
Table 160. Shanghai HeartCare Medical Technology Corporation Limited Product Models, Descriptions and Specifications
Table 161. Shanghai HeartCare Medical Technology Corporation Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Shanghai HeartCare Medical Technology Corporation Limited Recent Developments
Table 163. AccuMedical Beijing Inc. Corporation Information
Table 164. AccuMedical Beijing Inc. Description and Major Businesses
Table 165. AccuMedical Beijing Inc. Product Models, Descriptions and Specifications
Table 166. AccuMedical Beijing Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. AccuMedical Beijing Inc. Recent Developments
Table 168. Shanghai Achieva Medical Suzhou Co., Ltd. Corporation Information
Table 169. Shanghai Achieva Medical Suzhou Co., Ltd. Description and Major Businesses
Table 170. Shanghai Achieva Medical Suzhou Co., Ltd. Product Models, Descriptions and Specifications
Table 171. Shanghai Achieva Medical Suzhou Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. Shanghai Achieva Medical Suzhou Co., Ltd. Recent Developments
Table 173. Key Raw Materials Distribution
Table 174. Raw Materials Key Suppliers
Table 175. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 176. Milestones in Production Technology Evolution
Table 177. Distributors List
Table 178. Market Trends and Market Evolution
Table 179. Market Drivers and Opportunities
Table 180. Market Challenges, Risks, and Restraints
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources

List of Figures
Figure 1. Neurovascular Microcatheters Product Picture
Figure 2. Global Neurovascular Microcatheters Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Single-Lumen Microcatheters Product Picture
Figure 4. Dual-Lumen Balloon Microcatheters Product Picture
Figure 5. Global Neurovascular Microcatheters Market Size Growth Rate by Tip Shapeability, 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Steam-Shapeable Tip Product Picture
Figure 7. Fixed-Shape Tip Product Picture
Figure 8. Others Product Picture
Figure 9. Global Neurovascular Microcatheters Market Size Growth Rate by Radiopaque Marker Configuration, 2021 vs 2025 vs 2032 (US$ Million)
Figure 10. Single Distal Marker Product Picture
Figure 11. Dual Distal Markers Product Picture
Figure 12. Global Neurovascular Microcatheters Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 13. Intracranial Aneurysm
Figure 14. Arteriovenous Malformation and Fistula
Figure 15. Acute Ischemic Stroke
Figure 16. Others
Figure 17. Neurovascular Microcatheters Report Years Considered
Figure 18. Global Neurovascular Microcatheters Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 19. Global Neurovascular Microcatheters Revenue (US$ Million), 2021-2032
Figure 20. Global Neurovascular Microcatheters Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 21. Global Neurovascular Microcatheters Revenue-Based Market Share by Region (2021-2032)
Figure 22. Global Neurovascular Microcatheters Sales (K Units), 2021-2032
Figure 23. Global Neurovascular Microcatheters Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 24. Global Neurovascular Microcatheters Sales Market Share by Region (2021-2032)
Figure 25. Top 5 and Top 10 Manufacturers Neurovascular Microcatheters Sales Volume Market Share in 2025
Figure 26. Global Neurovascular Microcatheters Revenue-Based Market Share Ranking (2025)
Figure 27. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 28. Single-Lumen Microcatheters Revenue-Based Market Share by Manufacturer in 2025
Figure 29. Dual-Lumen Balloon Microcatheters Revenue-Based Market Share by Manufacturer in 2025
Figure 30. Global Neurovascular Microcatheters Sales Volume-Based Market Share by Type (2021-2032)
Figure 31. Global Neurovascular Microcatheters Revenue-Based Market Share by Type (2021-2032)
Figure 32. Global Neurovascular Microcatheters ASP by Type (US$/Unit), 2021-2032
Figure 33. Global Neurovascular Microcatheters Sales Volume-Based Market Share by Tip Shapeability (2021-2032)
Figure 34. Global Neurovascular Microcatheters Revenue-Based Market Share by Tip Shapeability (2021-2032)
Figure 35. Global Neurovascular Microcatheters ASP by Tip Shapeability (US$/Unit), 2021-2032
Figure 36. Global Neurovascular Microcatheters Sales Volume-Based Market Share by Radiopaque Marker Configuration (2021-2032)
Figure 37. Global Neurovascular Microcatheters Revenue-Based Market Share by Radiopaque Marker Configuration (2021-2032)
Figure 38. Global Neurovascular Microcatheters ASP by Radiopaque Marker Configuration (US$/Unit), 2021-2032
Figure 39. Global Neurovascular Microcatheters Sales Market Share by Application (2021-2032)
Figure 40. Global Neurovascular Microcatheters Revenue-Based Market Share by Application (2021-2032)
Figure 41. Global Neurovascular Microcatheters ASP by Application (US$/Unit), 2021-2032
Figure 42. North America Neurovascular Microcatheters Sales YoY (K Units), 2021-2032
Figure 43. North America Neurovascular Microcatheters Revenue YoY (US$ Million), 2021-2032
Figure 44. North America Top 5 Manufacturers Neurovascular Microcatheters Sales Revenue (US$ Million) in 2025
Figure 45. North America Neurovascular Microcatheters Sales Volume (K Units) by Application (2021-2032)
Figure 46. North America Neurovascular Microcatheters Sales Revenue (US$ Million) by Application (2021-2032)
Figure 47. US Neurovascular Microcatheters Revenue (US$ Million), 2021-2032
Figure 48. Canada Neurovascular Microcatheters Revenue (US$ Million), 2021-2032
Figure 49. Mexico Neurovascular Microcatheters Revenue (US$ Million), 2021-2032
Figure 50. Europe Neurovascular Microcatheters Sales YoY (K Units), 2021-2032
Figure 51. Europe Neurovascular Microcatheters Revenue YoY (US$ Million), 2021-2032
Figure 52. Europe Top 5 Manufacturers Neurovascular Microcatheters Sales Revenue (US$ Million) in 2025
Figure 53. Europe Neurovascular Microcatheters Sales Volume (K Units) by Application (2021-2032)
Figure 54. Europe Neurovascular Microcatheters Sales Revenue (US$ Million) by Application (2021-2032)
Figure 55. Germany Neurovascular Microcatheters Revenue (US$ Million), 2021-2032
Figure 56. France Neurovascular Microcatheters Revenue (US$ Million), 2021-2032
Figure 57. U.K. Neurovascular Microcatheters Revenue (US$ Million), 2021-2032
Figure 58. Italy Neurovascular Microcatheters Revenue (US$ Million), 2021-2032
Figure 59. Russia Neurovascular Microcatheters Revenue (US$ Million), 2021-2032
Figure 60. Asia-Pacific Neurovascular Microcatheters Sales YoY (K Units), 2021-2032
Figure 61. Asia-Pacific Neurovascular Microcatheters Revenue YoY (US$ Million), 2021-2032
Figure 62. Asia-Pacific Top 8 Manufacturers Neurovascular Microcatheters Sales Revenue (US$ Million) in 2025
Figure 63. Asia-Pacific Neurovascular Microcatheters Sales Volume (K Units) by Application (2021-2032)
Figure 64. Asia-Pacific Neurovascular Microcatheters Sales Revenue (US$ Million) by Application (2021-2032)
Figure 65. Indonesia Neurovascular Microcatheters Revenue (US$ Million), 2021-2032
Figure 66. Japan Neurovascular Microcatheters Revenue (US$ Million), 2021-2032
Figure 67. South Korea Neurovascular Microcatheters Revenue (US$ Million), 2021-2032
Figure 68. China Taiwan Neurovascular Microcatheters Revenue (US$ Million), 2021-2032
Figure 69. India Neurovascular Microcatheters Revenue (US$ Million), 2021-2032
Figure 70. Central and South America Neurovascular Microcatheters Sales YoY (K Units), 2021-2032
Figure 71. Central and South America Neurovascular Microcatheters Revenue YoY (US$ Million), 2021-2032
Figure 72. Central and South America Top 5 Manufacturers Neurovascular Microcatheters Sales Revenue (US$ Million) in 2025
Figure 73. Central and South America Neurovascular Microcatheters Sales Volume (K Units) by Application (2021-2032)
Figure 74. Central and South America Neurovascular Microcatheters Sales Revenue (US$ Million) by Application (2021-2032)
Figure 75. Brazil Neurovascular Microcatheters Revenue (US$ Million), 2021-2032
Figure 76. Argentina Neurovascular Microcatheters Revenue (US$ Million), 2021-2032
Figure 77. Middle East, and Africa Neurovascular Microcatheters Sales YoY (K Units), 2021-2032
Figure 78. Middle East and Africa Neurovascular Microcatheters Revenue YoY (US$ Million), 2021-2032
Figure 79. Middle East and Africa Top 5 Manufacturers Neurovascular Microcatheters Sales Revenue (US$ Million) in 2025
Figure 80. Middle East and Africa Neurovascular Microcatheters Sales Volume (K Units) by Application (2021-2032)
Figure 81. Middle East and Africa Neurovascular Microcatheters Sales Revenue (US$ Million) by Application (2021-2032)
Figure 82. GCC Countries Neurovascular Microcatheters Revenue (US$ Million), 2021-2032
Figure 83. Turkey Neurovascular Microcatheters Revenue (US$ Million), 2021-2032
Figure 84. Egypt Neurovascular Microcatheters Revenue (US$ Million), 2021-2032
Figure 85. South Africa Neurovascular Microcatheters Revenue (US$ Million), 2021-2032
Figure 86. Neurovascular Microcatheters Industry Chain Mapping
Figure 87. Regional Neurovascular Microcatheters Manufacturing Base Distribution (%)
Figure 88. Global Neurovascular Microcatheters Production Market Share by Region (2021-2032)
Figure 89. Neurovascular Microcatheters Production Process
Figure 90. Regional Neurovascular Microcatheters Production Cost Structure
Figure 91. Channels of Distribution (Direct Vs Distribution)
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed